High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.

D Mutimer; D Pillay; E Dragon; H Tang; M Ahmed; K O'Donnell; J Shaw; N Burroughs; D Rand; P Cane

doi:10.1016/s0168-8278(99)80204-9

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.

Identifier:nobleid.org/w1/20260515/FFC7F698

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FFC7F698.svg?ark=w1%2F20260515%2FFFC7F698)](https://nobleid.org/work/w1/20260515/FFC7F698)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.

Identifier:nobleid.org/w1/20260515/FFC7F698

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FFC7F698.svg?ark=w1%2F20260515%2FFFC7F698)](https://nobleid.org/work/w1/20260515/FFC7F698)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work